债务 更改 日
Agios Pharmaceuticals USD 31.17M 4.57M 2026-06
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Arrowhead Research USD 983.69M 5.77M 2026-06
Astellas Pharma JPY 589.87B 23.92B 2026-06
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
BioMarin Pharmaceutical USD 4.19B 11.99M 2026-09
Celltrion KRW 160.15B 428.19M 2026-06
Cspc Pharmaceutical CNY 641.11M 146.11M 2025-12
Deva Holding AS TRY 5.3B 871.93M 2023-09
Divis Laboratories Ltd INR 70M 30M 2026-03
Exelixis USD 162.2M 3.73M 2026-09
Halozyme Therapeutics USD 2.15B 2.02M 2026-06
Ionis Pharmaceuticals USD 1.77B 141M 2026-09
Kangmei Pharma CNY 173.71M 42.08M 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Moderna USD 1.29B 11M 2026-06
Nektar Therapeutics USD 0 0 2022-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Neurocrine Biosciences USD 392.3M 9.5M 2026-09
Novartis USD 49.01B 2.02B 2026-06
Omeros USD 442.16M 199K 2023-09
OPKO Health USD 398.08M 1.16M 2026-06
Organigram Holdings CAD 31.45M 23.26M 2026-06
Ovoca Bio EUR 0 0 2021-06
Pfizer USD 62.67B 523M 2026-09
Pharma Mar EUR 45.84M 1.7M 2026-06
PTC Therapeutics USD 2.84B 2.15B 2026-09
Qiagen NV USD 1.64B 2.94M 2026-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sarepta Therapeutics USD 857.36M 188.48M 2026-09
Sartorius EUR 4.05B 248.8M 2026-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Tilray USD 640.95M 35.17M 2022-06
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 6.48B 4.5B 2026-09
Zealand Pharma A/S 414M 8.23M 2026-03
Zz Pientze Pharmaceu CNY 1.03B 34.23M 2026-06